ArticleFrontiers in pharmacology2015

Though Active on RINm5F Insulinoma Cells and Cultured Pancreatic Islets, Recombinant IL-22 Fails to Modulate Cytotoxicity and Disease in a Protocol of Streptozotocin-Induced Experimental Diabetes.

Anika Berner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.